Anti-inflammatory Effects of Vicenin-2 and Scolymoside in Vitro and in Vivo
Overview
Pathology
Affiliations
Aim And Objective: Two structurally related flavonoids found in Cyclopia subternata, namely vicenin-2 and scolymoside, were examined for its effects on inflammatory responses by monitoring the effects of vicenin-2 and scolymoside on lipopolysaccharide (LPS)-mediated vascular inflammatory responses.
Methods: The anti-inflammatory activities of vicenin-2 and scolymoside were determined by measuring permeability,monocytes adhesion and migration, and activation of pro-inflammatory proteins in LPS-activated HUVECs and mice.
Results: We found that post-treatment of each compound inhibited LPS-induced barrier disruption, expression of cell adhesion molecules (CAMs), and adhesion/transendothelial migration of human neutrophils to human endothelial cells. Each compound induced potent inhibition of phorbol-12-myristate 13-acetate (PMA) and LPS-induced endothelial cell protein C receptor (EPCR)shedding. It also suppressed LPS-induced hyperpermeability and leukocytes migration in vivo. Furthermore,each compound suppressed the production of tumor necrosis factor-α (TNF-α) or Interleukin (IL)-6 and the activation of nuclear factor-κB (NF-κB) or extracellular regulated kinases (ERK) 1/2 by LPS. Moreover, posttreatment with each compound resulted in reduced LPS-induced lethal endotoxemia.
Conclusion: Vicenin-2 and scolymoside possess anti-inflammatory functions by inhibiting hyperpermeability,expression of CAMs, and adhesion and migration of leukocytes, thereby endorsing its usefulness as a therapy for vascular inflammatory diseases.
Maugeri A, Russo C, Patane G, Farina M, Rapisarda A, Masullo M Int J Mol Sci. 2025; 26(5).
PMID: 40076701 PMC: 11900626. DOI: 10.3390/ijms26052077.
Identification of novel cyclin-dependent kinase 4/6 inhibitors from marine natural products.
Debnath A, Mazumder R, Singh A, Singh R PLoS One. 2025; 20(1):e0313830.
PMID: 39813224 PMC: 11734976. DOI: 10.1371/journal.pone.0313830.
Kantasrila R, Pandith H, Balslev H, Wangpakapattanawong P, Panyadee P, Inta A Pharm Biol. 2023; 62(1):62-104.
PMID: 38131672 PMC: 10763916. DOI: 10.1080/13880209.2023.2292261.
Guo Y, Jiang Y, Li Y, Kurihara H, Dai Y, He R Front Pharmacol. 2020; 10:1564.
PMID: 32038243 PMC: 6987446. DOI: 10.3389/fphar.2019.01564.
Lee I, Bae J J Nat Med. 2019; 74(1):90-97.
PMID: 31350693 DOI: 10.1007/s11418-019-01348-x.